Cell-Free DNA From Nontumor Tissue in Patients With Non-small Cell Lung Cancer

被引：1
|
作者：
Goto, Taichiro [1 ]
机构：
[1] Yamanashi Cent Hosp, Lung Canc & Resp Dis Ctr, Yamanashi, Japan
来源：
CHEST | 2021年 / 160卷 / 04期
关键词：
CIRCULATING TUMOR DNA;
D O I：
10.1016/j.chest.2021.05.072
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：E370 / E371
页数：2
相关论文
共 50 条
  • [41] The value of cell-free circulating tumour DNA profiling in advanced non-small cell lung cancer (NSCLC) management
    Fernandes, Maria Gabriela O.
    Cruz-Martins, Natalia
    Machado, Jose Carlos
    Costa, Jose Luis
    Hespanhol, Venceslau
    CANCER CELL INTERNATIONAL, 2021, 21 (01)
  • [42] Detection and comparison of EGFR mutations from supernatants that contain cell-free DNA and cell pellets from FNA non-small cell lung cancer specimens
    Wu, Wei
    Huang, Yan
    Guo, Junhong
    Xie, Xiaofeng
    Li, Hui
    Cao, Ziyang
    Wei, Haiting
    Wu, Chunyan
    CANCER CYTOPATHOLOGY, 2020, 128 (08) : 545 - 552
  • [43] Spectrum of 1,014 Somatic BRAF Alterations Detected in Cell-Free DNA of Patients with Advanced Non-Small Cell Lung Cancer
    Raymond, V.
    Bivona, T.
    Lanman, R.
    Nagy, R.
    Banks, K.
    Chae, Y. K.
    Clarke, J.
    Crawford, J.
    Gandara, D. R.
    Heymach, J.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1777 - S1778
  • [44] Detection of tumor-associated gene mutations in cell-free DNA of early-stage non-small cell lung cancer patients
    Kimura, H.
    Koba, H.
    Kasahara, K.
    CLINICAL & EXPERIMENTAL METASTASIS, 2018, 35 (03) : 192 - 192
  • [45] Plasma Cell-Free DNA as a Point-of-Care Wellbeing Biomarker for Early-Stage Non-Small Cell Lung Cancer Patients
    McGuire, A. L.
    Sharma, S.
    Hilzenrat, R. A.
    McConechy, M. K.
    Frank, I. R.
    Hughesman, C.
    Yip, S.
    Choi, J. J.
    Yee, J.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S197 - S197
  • [46] Performance of Super ARMS to Detect EGFR Mutation Status in Plasma Cell-free DNA in Advanced Non-Small Cell Lung Cancer Patients
    Li, Yuping
    Xu, Hanyan
    Su, Shanshan
    Yang, Li
    Ye, Junru
    Chen, Chengshui
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [47] Plasma cell-free DNA methylation combined with tumor mutation detection in prognostic prediction of patients with non-small cell lung cancer (NSCLC)
    Guo, Dan
    Yang, Liang
    Yang, Jianwei
    Shi, Ke
    MEDICINE, 2020, 99 (26) : E20431
  • [48] Total and mutated EGFR quantification in cell-free DNA from non-small cell lung cancer patients detects tumor heterogeneity and presents prognostic value
    Alegre, E.
    Fusco, J. P.
    Restituto, P.
    Salas-Benito, D.
    Rodriguez-Ruiz, M. E.
    Andueza, M. P.
    Pajares, M. J.
    Patino-Garcia, A.
    Pio, R.
    Lozano, M. D.
    Gurpide, A.
    Lopez-Picazo, J. M.
    Gil-Bazo, I.
    Perez-Gracia, J. L.
    Gonzalez, A.
    TUMOR BIOLOGY, 2016, 37 (10) : 13687 - 13694
  • [49] Comparison of plasma to tissue DNA mutations in surgical patients with non-small cell lung cancer
    Chen, Kezhong
    Zhang, Jingbo
    Guan, Tian
    Yang, Fan
    Lou, Feng
    Chen, Wei
    Zhao, Mingyu
    Zhang, Jay
    Chen, Siyi
    Wang, Jun
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2017, 154 (03): : 1123 - 1130
  • [50] Circulating cell free DNA during chemo-radiotherapy in non-small cell lung cancer patients
    Nygaard, L.
    Ahlborn, L.
    Persson, G.
    Chandrananda, D.
    Langer, J.
    Fischer, B. M.
    Aznar, M.
    Langer, S.
    Gabrielaite, M.
    Kjaer, A.
    Rosenfeld, N.
    Mouliere, F.
    Ostrup, O.
    Vogelius, I.
    Bentzen, S.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S747 - S748
12345